Tag: brokered

The base shelf prospectus is accessible, and the prospectus supplement will be accessible within two business days, through SEDAR+

CALGARY, ALBERTA, June 02, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a global leader in SaaS clinical division support solutions, is pleased to announce that, the Company intends to complete a non-brokered private placement (the “Offering”) of up to 4,642,857 units in the capital of the Company (each, a “Unit”) for gross proceeds of up to CDN$1,300,000, at a price of $0.28 per Unit. Each Unit is comprised of one common share in the capital of the Company (each, a “Common Share”) and one common share purchase warrant (each, a “Warrant”). Each Warrant is exercisable to acquire one Common Share at a price of CDN$0.50 for a period of 36 months.

All dollar amounts reflected in Canadian dollars unless otherwise stated.

MONTREAL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news release date July 30, 2025, the Company voluntarily applied for and the Company’s principal regulator, the British Columbia Securities Commission (the “BCSC”) granted a management cease trade order (the “MCTO”) dated July 30, 2025, under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”) and provided the Company with an extension to file its annual financial statements for the period ended March 31, 2025, including the related management’s discussion and analysis, and related certifications on or before July 29, 2025 (collectively the “Annual Financial Filings”). The deadline has now been extended to on or before September 29, 2025.

LEADING EDGE MATERIALS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT

BROSSARD, Quebec, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces that it intends to extend the exercise period of an aggregate of 650,000 stock warrants (each a “Warrant”) issued as part of a non-brokered private placement of units initially announced on March 22, 2024. The Warrants initial exercise period is set to expire on September 22, 2025.